Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Zynerba Pharmaceuticals, Inc. (ZYNE) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/11/2023 8-K Quarterly results
08/14/2023 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "AGREEMENT AND PLAN OF MERGER   by and among   HARMONY BIOSCIENCES HOLDINGS, INC.,   XYLOPHONE ACQUISITION CORP.   and   ZYNERBA PHARMACEUTICALS, INC.",
"AMENDMENT TO EMPLOYMENT AGREEMENT",
"AMENDMENT TO EMPLOYMENT AGREEMENT",
"AMENDMENT TO EMPLOYMENT AGREEMENT",
"Execution Version TENDER AND SUPPORT AGREEMENT",
"HARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC."
05/15/2023 8-K Quarterly results
Docs: "Zynerba Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Highlights",
"FIRST AND ONLY TRANSDERMAL CANNABIDIOL GEL"
05/04/2023 8-K Quarterly results
03/28/2023 8-K Quarterly results
01/09/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "FIRST AND ONLY TRANSDERMAL CANNABIDIOL GEL"
12/21/2022 8-K Quarterly results
12/05/2022 8-K Quarterly results
11/15/2022 8-K Quarterly results
11/14/2022 8-K Quarterly results
11/04/2022 8-K Quarterly results
09/13/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "FIRST AND ONLY TRANSDERMAL CANNABIDIOL GEL"
08/10/2022 8-K Quarterly results
07/21/2022 8-K Quarterly results
06/22/2022 8-K Quarterly results
06/16/2022 8-K Quarterly results
06/01/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Zynerba Pharmaceuticals Presents Data on Zygel™ at the American Society of Clinical Psychopharmacology Annual Meeting"
05/16/2022 8-K Quarterly results
03/01/2022 8-K Quarterly results
02/28/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Zynerba Pharmaceuticals Announces Completion of Enrollment in Phase 2 Trial of Zygel™ in 22q11.2 Deletion Syndrome",
"Zynerba Pharmaceuticals Announces European Commission Has Granted Orphan Drug Designation for Zygel ™ in Fragile X Syndrome"
01/04/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Zynerba Pharmaceuticals Announces Clinical Development Updates for FXS, ASD, 22q and DEE",
"THE STATEMENTS IN THIS PRESENTATION MAY INCLUDE FORWARD"
11/22/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Zynerba Pharmaceuticals Announces Issuance of New Patent in EU for Zygel&trade"
11/15/2021 8-K Quarterly results
Docs: "Zynerba Pharmaceuticals Reports Third Quarter 2021 Financial Results and Operational Highlights",
"THE STATEMENTS IN THIS PRESENTATION MAY INCLUDE FORWARD"
09/13/2021 8-K Quarterly results
09/09/2021 8-K Quarterly results
09/07/2021 8-K Quarterly results
08/09/2021 8-K Quarterly results
08/05/2021 8-K Quarterly results
07/30/2021 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "CERTIFICATE OF AMENDMENT"
07/14/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "THE STATEMENTS IN THIS PRESENTATION MAY INCLUDE FORWARD"
06/30/2021 8-K Quarterly results
06/09/2021 8-K Quarterly results
05/26/2021 8-K Quarterly results
05/12/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy